{
    "startDate": "2017-01-01",
    "endDate": "2017-12-31",
    "year": "2017",
    "quarter": "FY",
    "symbol": "BIIB",
    "data": {
        "bs": [
            {
                "label": "Cash and cash equivalents",
                "concept": "CashAndCashEquivalentsAtCarryingValue",
                "unit": "usd",
                "value": 1573800000
            },
            {
                "label": "Marketable securities",
                "concept": "AvailableForSaleSecuritiesCurrent",
                "unit": "usd",
                "value": 2115200000
            },
            {
                "label": "Accounts receivable, net",
                "concept": "AccountsReceivableNetCurrent",
                "unit": "usd",
                "value": 1787000000
            },
            {
                "label": "Due from anti-CD20 therapeutic programs",
                "concept": "biib:DueFromUnconsolidatedJointBusiness",
                "unit": "usd",
                "value": 532600000
            },
            {
                "label": "Inventory",
                "concept": "InventoryNet",
                "unit": "usd",
                "value": 902700000
            },
            {
                "label": "Other current assets",
                "concept": "OtherAssetsCurrent",
                "unit": "usd",
                "value": 962000000
            },
            {
                "label": "Current assets:",
                "concept": "AssetsCurrent",
                "unit": "usd",
                "value": 7873300000
            },
            {
                "label": "Marketable securities",
                "concept": "AvailableForSaleSecuritiesNoncurrent",
                "unit": "usd",
                "value": 3057300000
            },
            {
                "label": "Property, plant and equipment, net",
                "concept": "PropertyPlantAndEquipmentNet",
                "unit": "usd",
                "value": 3182400000
            },
            {
                "label": "Intangible assets, net",
                "concept": "IntangibleAssetsNetExcludingGoodwill",
                "unit": "usd",
                "value": 3879600000
            },
            {
                "label": "Goodwill",
                "concept": "Goodwill",
                "unit": "usd",
                "value": 4632500000
            },
            {
                "label": "Investments and other assets",
                "concept": "OtherAssetsNoncurrent",
                "unit": "usd",
                "value": 1027500000
            },
            {
                "label": "ASSETS",
                "concept": "Assets",
                "unit": "usd",
                "value": 23652600000
            },
            {
                "label": "Current portion of notes payable and other financing arrangements",
                "concept": "DebtCurrent",
                "unit": "usd",
                "value": 3200000
            },
            {
                "label": "Taxes payable",
                "concept": "TaxesPayableCurrent",
                "unit": "usd",
                "value": 68200000
            },
            {
                "label": "Accounts payable",
                "concept": "AccountsPayableCurrent",
                "unit": "usd",
                "value": 395500000
            },
            {
                "label": "Accrued expenses and other",
                "concept": "OtherLiabilitiesCurrent",
                "unit": "usd",
                "value": 2901300000
            },
            {
                "label": "Current liabilities:",
                "concept": "LiabilitiesCurrent",
                "unit": "usd",
                "value": 3368200000
            },
            {
                "label": "Notes payable and other financing arrangements",
                "concept": "LongTermDebt",
                "unit": "usd",
                "value": 5935000000
            },
            {
                "label": "Deferred tax liability",
                "concept": "DeferredTaxLiabilitiesNoncurrent",
                "unit": "usd",
                "value": 122600000
            },
            {
                "label": "Other long-term liabilities",
                "concept": "OtherLiabilitiesNoncurrent",
                "unit": "usd",
                "value": 1628700000
            },
            {
                "label": "LIABILITIES AND EQUITY",
                "concept": "Liabilities",
                "unit": "usd",
                "value": 11054500000
            },
            {
                "label": "Commitments and contingencies",
                "concept": "CommitmentsAndContingencies",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Preferred stock, par value $0.001 per share",
                "concept": "PreferredStockValue",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Common stock, par value $0.0005 per share",
                "concept": "CommonStockValue",
                "unit": "usd",
                "value": 100000
            },
            {
                "label": "Additional paid-in capital",
                "concept": "AdditionalPaidInCapital",
                "unit": "usd",
                "value": 97800000
            },
            {
                "label": "Accumulated other comprehensive loss",
                "concept": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
                "unit": "usd",
                "value": -318400000
            },
            {
                "label": "Retained earnings",
                "concept": "RetainedEarningsAccumulatedDeficit",
                "unit": "usd",
                "value": 15810400000
            },
            {
                "label": "Treasury stock, at cost; 23.8 million and 22.6 million shares, respectively",
                "concept": "TreasuryStockValue",
                "unit": "usd",
                "value": 2977100000
            },
            {
                "label": "Equity:",
                "concept": "StockholdersEquity",
                "unit": "usd",
                "value": 12612800000
            },
            {
                "label": "Noncontrolling interests",
                "concept": "MinorityInterest",
                "unit": "usd",
                "value": -14700000
            },
            {
                "label": "Equity:",
                "concept": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
                "unit": "usd",
                "value": 12598100000
            },
            {
                "label": "LIABILITIES AND EQUITY",
                "concept": "LiabilitiesAndStockholdersEquity",
                "unit": "usd",
                "value": 23652600000
            }
        ],
        "cf": [
            {
                "label": "Net income",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": 2670100000
            },
            {
                "label": "Depreciation and amortization",
                "concept": "DepreciationDepletionAndAmortization",
                "unit": "usd",
                "value": 1081000000
            },
            {
                "label": "Acquired in-process research and development",
                "concept": "ResearchAndDevelopmentInProcess",
                "unit": "usd",
                "value": 120000000
            },
            {
                "label": "Share-based Compensation Arrangements by Share-based Payment Award, Award Type and Plan Name [Domain]",
                "concept": "ShareBasedCompensation",
                "unit": "usd",
                "value": 128000000
            },
            {
                "label": "Deferred",
                "concept": "DeferredIncomeTaxExpenseBenefit",
                "unit": "usd",
                "value": 91700000
            },
            {
                "label": "Loss (gain) on fair value remeasurement of contingent consideration",
                "concept": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings",
                "unit": "usd",
                "value": -62700000
            },
            {
                "label": "Other",
                "concept": "OtherNoncashIncomeExpense",
                "unit": "usd",
                "value": -162100000
            },
            {
                "label": "Accounts receivable",
                "concept": "IncreaseDecreaseInAccountsReceivable",
                "unit": "usd",
                "value": 435600000
            },
            {
                "label": "Due from anti-CD20 therapeutic programs",
                "concept": "IncreaseDecreaseInOtherOperatingCapitalNet",
                "unit": "usd",
                "value": 232000000
            },
            {
                "label": "Inventory",
                "concept": "IncreaseDecreaseInInventories",
                "unit": "usd",
                "value": 94500000
            },
            {
                "label": "Other assets",
                "concept": "IncreaseDecreaseInOtherOperatingAssets",
                "unit": "usd",
                "value": 76600000
            },
            {
                "label": "Accrued expenses and other current liabilities",
                "concept": "IncreaseDecreaseInAccruedLiabilities",
                "unit": "usd",
                "value": -227400000
            },
            {
                "label": "Income tax assets and liabilities",
                "concept": "IncreaseDecreaseInAccruedIncomeTaxesPayable",
                "unit": "usd",
                "value": 1303900000
            },
            {
                "label": "Other liabilities",
                "concept": "IncreaseDecreaseInOtherOperatingLiabilities",
                "unit": "usd",
                "value": -2400000
            },
            {
                "label": "Cash flows from operating activities:",
                "concept": "NetCashProvidedByUsedInOperatingActivities",
                "unit": "usd",
                "value": 4551000000
            },
            {
                "label": "Proceeds from maturities and sales",
                "concept": "ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities",
                "unit": "usd",
                "value": 5565900000
            },
            {
                "label": "Purchases of marketable securities",
                "concept": "PaymentsToAcquireAvailableForSaleSecurities",
                "unit": "usd",
                "value": 5355200000
            },
            {
                "label": "Contingent consideration related to Fumapharm AG acquisition",
                "concept": "PaymentsToAcquireOtherProductiveAssets",
                "unit": "usd",
                "value": 1200000000
            },
            {
                "label": "Payments to Acquire in Process Research and Development",
                "concept": "PaymentsToAcquireInProcessResearchAndDevelopment",
                "unit": "usd",
                "value": 120000000
            },
            {
                "label": "Acquisitions of businesses, net of cash acquired",
                "concept": "PaymentsToAcquireBusinessesNetOfCashAcquired",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Purchases of property, plant and equipment",
                "concept": "PaymentsToAcquirePropertyPlantAndEquipment",
                "unit": "usd",
                "value": 867400000
            },
            {
                "label": "Acquisitions of intangible assets",
                "concept": "PaymentsToAcquireIntangibleAssets",
                "unit": "usd",
                "value": 975400000
            },
            {
                "label": "Other",
                "concept": "PaymentsForProceedsFromOtherInvestingActivities",
                "unit": "usd",
                "value": 11000000
            },
            {
                "label": "Cash flows from investing activities:",
                "concept": "NetCashProvidedByUsedInInvestingActivities",
                "unit": "usd",
                "value": -2963100000
            },
            {
                "label": "Purchases of treasury stock",
                "concept": "PaymentsForRepurchaseOfCommonStock",
                "unit": "usd",
                "value": 1365400000
            },
            {
                "label": "Payments related to issuance of stock for share-based compensation arrangements, net",
                "concept": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation",
                "unit": "usd",
                "value": 5300000
            },
            {
                "label": "Net distribution to noncontrolling interest",
                "concept": "PaymentsToMinorityShareholders",
                "unit": "usd",
                "value": 134100000
            },
            {
                "label": "Proceeds from borrowings",
                "concept": "ProceedsFromNotesPayable",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Repayments of borrowings",
                "concept": "RepaymentsOfDebt",
                "unit": "usd",
                "value": 560900000
            },
            {
                "label": "Net cash contribution to Bioverativ, Inc.",
                "concept": "PaymentsOfCapitalDistribution",
                "unit": "usd",
                "value": 302700000
            },
            {
                "label": "Contingent consideration payments",
                "concept": "PaymentsToAcquireProductiveAssets",
                "unit": "usd",
                "value": 3000000
            },
            {
                "label": "Other",
                "concept": "ProceedsFromPaymentsForOtherFinancingActivities",
                "unit": "usd",
                "value": -8600000
            },
            {
                "label": "Cash flows from financing activities:",
                "concept": "NetCashProvidedByUsedInFinancingActivities",
                "unit": "usd",
                "value": -2380000000
            },
            {
                "label": "Net increase in cash and cash equivalents",
                "concept": "CashAndCashEquivalentsPeriodIncreaseDecrease",
                "unit": "usd",
                "value": -792100000
            },
            {
                "label": "Effect of exchange rate changes on cash and cash equivalents",
                "concept": "EffectOfExchangeRateOnCashAndCashEquivalents",
                "unit": "usd",
                "value": 39400000
            }
        ],
        "ic": [
            {
                "label": "Net income attributable to Biogen Inc.",
                "concept": "NetIncomeLoss",
                "unit": "usd",
                "value": 2539100000
            },
            {
                "label": "Unrealized gains (losses) recognized during the period, net of tax",
                "concept": "OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax",
                "unit": "usd",
                "value": -3500000
            },
            {
                "label": "Less: reclassification adjustment for (gains) losses included in net income, net of tax",
                "concept": "OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax",
                "unit": "usd",
                "value": -12700000
            },
            {
                "label": "Unrealized gains (losses) on securities available for sale, net of tax",
                "concept": "OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax",
                "unit": "usd",
                "value": 9200000
            },
            {
                "label": "Unrealized gains (losses) recognized during the period, net of tax",
                "concept": "OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax",
                "unit": "usd",
                "value": -193800000
            },
            {
                "label": "Less: reclassification adjustment for (gains) losses included in net income, net of tax",
                "concept": "OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax",
                "unit": "usd",
                "value": -31500000
            },
            {
                "label": "Unrealized gains (losses) on cash flow hedges, net of tax",
                "concept": "OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax",
                "unit": "usd",
                "value": -162300000
            },
            {
                "label": "Unrealized gains (losses) on pension benefit obligation, net of tax",
                "concept": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax",
                "unit": "usd",
                "value": 4100000
            },
            {
                "label": "Currency translation adjustment",
                "concept": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
                "unit": "usd",
                "value": 158700000
            },
            {
                "label": "Net current period other comprehensive income (loss)",
                "concept": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
                "unit": "usd",
                "value": 1500000
            },
            {
                "label": "Comprehensive income attributable to Biogen Inc.",
                "concept": "ComprehensiveIncomeNetOfTax",
                "unit": "usd",
                "value": 2540600000
            },
            {
                "label": "Comprehensive income (loss) attributable to noncontrolling interests, net of tax",
                "concept": "ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest",
                "unit": "usd",
                "value": -131000000
            },
            {
                "label": "Comprehensive income",
                "concept": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
                "unit": "usd",
                "value": 2671600000
            },
            {
                "label": "Product, net",
                "concept": "SalesRevenueGoodsNet",
                "unit": "usd",
                "value": 10354700000
            },
            {
                "label": "Revenues from anti-CD20 therapeutic programs",
                "concept": "biib:RevenuesfromantiCD20therapeuticprograms",
                "unit": "usd",
                "value": 1559200000
            },
            {
                "label": "Other",
                "concept": "OtherSalesRevenueNet",
                "unit": "usd",
                "value": 360000000
            },
            {
                "label": "Product revenues, net",
                "concept": "Revenues",
                "unit": "usd",
                "value": 12273900000
            },
            {
                "label": "Cost of sales",
                "concept": "CostOfGoodsSold",
                "unit": "usd",
                "value": 1630000000
            },
            {
                "label": "Research and development",
                "concept": "ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost",
                "unit": "usd",
                "value": 2253600000
            },
            {
                "label": "Selling, general and administrative",
                "concept": "SellingGeneralAndAdministrativeExpense",
                "unit": "usd",
                "value": 1935500000
            },
            {
                "label": "Amortization of Intangible Assets",
                "concept": "AmortizationOfIntangibleAssets",
                "unit": "usd",
                "value": 814700000
            },
            {
                "label": "Acquired in-process research and development",
                "concept": "ResearchAndDevelopmentInProcess",
                "unit": "usd",
                "value": 120000000
            },
            {
                "label": "Collaboration profit (loss) sharing",
                "concept": "biib:CollaborationProfitSharing",
                "unit": "usd",
                "value": 112300000
            },
            {
                "label": "Loss (gain) on fair value remeasurement of contingent consideration",
                "concept": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings",
                "unit": "usd",
                "value": -62700000
            },
            {
                "label": "Restructuring charges",
                "concept": "RestructuringCharges",
                "unit": "usd",
                "value": 900000
            },
            {
                "label": "TECFIDERA litigation settlement charge",
                "concept": "LitigationSettlementExpense",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Costs and expenses",
                "concept": "CostsAndExpenses",
                "unit": "usd",
                "value": 6929700000
            },
            {
                "label": "Income from operations",
                "concept": "OperatingIncomeLoss",
                "unit": "usd",
                "value": 5344200000
            },
            {
                "label": "Nonoperating Income (Expense)",
                "concept": "NonoperatingIncomeExpense",
                "unit": "usd",
                "value": -215400000
            },
            {
                "label": "Income before income taxes (benefit):",
                "concept": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
                "unit": "usd",
                "value": 5128800000
            },
            {
                "label": "Income tax benefit (expense)",
                "concept": "IncomeTaxExpenseBenefit",
                "unit": "usd",
                "value": 2458700000
            },
            {
                "label": "Equity in loss of investee, net of tax",
                "concept": "IncomeLossFromEquityMethodInvestments",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Net income",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": 2670100000
            },
            {
                "label": "Net income (loss) attributable to noncontrolling interests, net of tax",
                "concept": "NetIncomeLossAttributableToNoncontrollingInterest",
                "unit": "usd",
                "value": 131000000
            },
            {
                "label": "Basic earnings per share attributable to Biogen Inc.",
                "concept": "EarningsPerShareBasic",
                "unit": "usd/shares",
                "value": 11.94
            },
            {
                "label": "Diluted earnings per share attributable to Biogen Inc.",
                "concept": "EarningsPerShareDiluted",
                "unit": "usd/shares",
                "value": 11.92
            },
            {
                "label": "Basic earnings per share attributable to Biogen Inc.",
                "concept": "WeightedAverageNumberOfSharesOutstandingBasic",
                "unit": "shares",
                "value": 212600000
            },
            {
                "label": "Diluted earnings per share attributable to Biogen Inc.",
                "concept": "WeightedAverageNumberOfDilutedSharesOutstanding",
                "unit": "shares",
                "value": 213000000
            }
        ]
    }
}